Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma

Clinical Cancer Research

Volumn 9, Issue 9, 2003, Pages 3425-3430

  Cohen, Erik G ^a   Almahmeed, Taghreed ^a   Du, Baoheng ^b   Golijanin, Dragan ^a   Boyle, Jay O ^a   Soslow, Robert A ^a   Subbaramaiah, Kotha ^b   Dannenberg, Andrew J ^b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSOMAL PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTANOID RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL TRANSFORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROSOME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLORING AGENTS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; MICROSOMES; MUCOUS MEMBRANE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 0042334817     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jung, T. T., Berlinger, N. T., and Juhn, S. K. Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study. Laryngoscope, 95: 307-312, 1985.
2. Gallo, O., Masini, E., Bianchi, B., Bruschini, L., Paglierani, M., and Franchi, A. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum. Pathol., 33: 708-714, 2002.
3. 2 in human colon cancer cells. Cancer Res., 58: 362-366, 1998.
4. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276: 18075-18081, 2001.
5. Tsujii, M., and DuBois, R. N. Alterations in cellular adehesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83: 493-501, 1995.
6. Goodwin, J. S., Bankhurst, A. D., and Messner, R. P. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin producing suppressor cell. J. Exp. Med., 146: 1719-1734, 1977.
7. Goodwin, J. S., and Ceuppens, J. Regulation of immune response by prostaglandins. J. Clin. Immunol., 3: 295-315, 1983.
8. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery, 95: 71-77, 1984.
9. Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., Wollman, J., Herschman, H., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998.
10. Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B. Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., Lee, J. C., and Dubinett, S. M. Specific inhibition of cyclooxygenase-2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol., 164: 361-370, 2000.
11. Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1; a potential mechanism for inflammatory angiogenesis. FEBS Lett., 372: 83-87, 1995.
12. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998.
13. Gallo, O., Franchi, A., Magnelli, L., Sardi, I., Vannacci, A., Boddi, V., Chiarugi, V., and Masini, E. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia, 3: 53-61, 2001.
14. 716 knockout mice. Nat. Med., 7: 1048-1051, 2001.
15. 2 in human head and neck xenograft tumors. Cancer Res., 62: 6706-6711, 2002.
16. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59: 991-994, 1999.
17. Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., and Subbaramaiah, K. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2: 544-551, 2001.
18. Jakobsson, P. J., Thoren, S., Morgenstern, R., and Samuelsson, B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA, 96: 7220-7225, 1999.
19. Yoshimatsu, K., Golijanin, D., Paty, P. B., Soslow, R. A., Jakobsson, P. J., DeLellis, R. A., Subbaramaiah, K., and Dannenberg, A. J. Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin. Cancer Res., 7: 3971-3976, 2001.
20. Yoshimatsu, K., Altorki, N. K., Golijanin, D., Zhang, F., Jakobsson, P. J., Dannenberg, A. J., and Subbaramaiah, K. Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin. Cancer Res., 7: 2669-2674, 2001.
21. 4 receptors. Br. J. Cancer, 85: 1023-1031, 2001.
22. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B. Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 56: 4424-4429, 1996.
23. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res., 48: 2858-2866, 1988.
24. Hoteiya, T., Hayashi, E., Satomura, K., Kamata, N., and Nagayama, M. Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J. Oral Pathol. Med., 28: 107-111, 1999.
25. Sacks, P. G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastisis Rev., 15: 27-51, 1996.
26. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randell, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
27. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29: e45, 2001.
28. Kawamori, T., Uchiya, N., Nakatsugi, S., Watanabe, K., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Sugimura, T., and Wakabayashi, K. Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development. Carcinogenesis (Lond.), 22: 2001-2004, 2001.
29. Kawamori, T., Uchiya, N., Kitamura, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Sugimura, T., and Wakabayashi, K. Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. Anticancer Res., 21: 3865-3869, 2001.
30. 716 mouse intestinal polyps. Cancer Res., 62: 506-511, 2002.
31. Stichtenoth, D. O., Thoren, S., Bian, H., Peters-Golden, M., Jakobsson, P. J., and Crofford, L. J. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J. Immunol., 167: 469-474, 2001.
32. 2 synthase expression. J. Biol. Chem., 277: 16355-16364, 2002.
33. Keith, R. L., Miller, Y. E., Hoshikawa, Y., Moore, M. D., Gesell, T. L., Gao, B., Malkinson, A. M., Golpon, H. A., Nemenoff, R. A., and Geraci, M. W. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res., 62: 734-740, 2002.
34. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem., 275: 32783-32792, 2000.